Characterization of potential biomarkers of reactogenicity of licensed antiviral vaccines: randomized controlled clinical trials conducted by the BIOVACSAFE consortium

Biomarkers predictive of inflammatory events post-vaccination could accelerate vaccine development. Within the BIOVACSAFE framework, we conducted three identically designed, placebo-controlled inpatient/outpatient clinical studies (NCT01765413/NCT01771354/NCT01771367). Six antiviral vaccination stra...

Descripción completa

Detalles Bibliográficos
Autores principales: Weiner, January, Lewis, David J. M., Maertzdorf, Jeroen, Mollenkopf, Hans-Joachim, Bodinham, Caroline, Pizzoferro, Kat, Linley, Catherine, Greenwood, Aldona, Mantovani, Alberto, Bottazzi, Barbara, Denoel, Philippe, Leroux-Roels, Geert, Kester, Kent E., Jonsdottir, Ingileif, van den Berg, Robert, Kaufmann, Stefan H. E., Del Giudice, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937244/
https://www.ncbi.nlm.nih.gov/pubmed/31889148
http://dx.doi.org/10.1038/s41598-019-56994-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937244/
https://www.ncbi.nlm.nih.gov/pubmed/31889148
http://dx.doi.org/10.1038/s41598-019-56994-8

Ejemplares similares